Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss KROS - Keros Therapeutics, Inc.
0
LAST VALUE
100.00%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR